Evidence map›Paper›PMID 37362343›Full record

ArticleRSC advances2023

Mesoporous silica nanoparticles with dual-targeting agricultural sources for enhanced cancer treatment

Yu-Ya Huang, Zui-Harng Lee, Kai-Chi Chang, Zhi-Yuan Wu, Cheng-Chang Lee, Min-Hsuan Tsou, Hsiu-Mei Lin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yu-Ya HuangNational Taiwan Ocean University, Department of Bioscience and Biotechnology No. 2, Beining Rd., Zhongzheng Dist. Keelung City 202 Taiwan Republic of China hmlin@mail.ntou.edu.tw +886-2-2462-2192 +886-2-2462-2192.
Zui-Harng LeeNational Taiwan Ocean University, Department of Bioscience and Biotechnology No. 2, Beining Rd., Zhongzheng Dist. Keelung City 202 Taiwan Republic of China hmlin@mail.ntou.edu.tw +886-2-2462-2192 +886-2-2462-2192.
Kai-Chi ChangNational Taiwan Ocean University, Bachelor Degree Program in Marine Biotechenology Taiwan.ORCID https://orcid.org/0000-0002-5185-7448
Zhi-Yuan WuNational Taiwan Ocean University, Department of Bioscience and Biotechnology No. 2, Beining Rd., Zhongzheng Dist. Keelung City 202 Taiwan Republic of China hmlin@mail.ntou.edu.tw +886-2-2462-2192 +886-2-2462-2192.
Cheng-Chang LeeNational Taiwan Ocean University, Department of Bioscience and Biotechnology No. 2, Beining Rd., Zhongzheng Dist. Keelung City 202 Taiwan Republic of China hmlin@mail.ntou.edu.tw +886-2-2462-2192 +886-2-2462-2192.
Min-Hsuan TsouNational Taiwan Ocean University, Department of Bioscience and Biotechnology No. 2, Beining Rd., Zhongzheng Dist. Keelung City 202 Taiwan Republic of China hmlin@mail.ntou.edu.tw +886-2-2462-2192 +886-2-2462-2192.
Hsiu-Mei LinNational Taiwan Ocean University, Department of Bioscience and Biotechnology No. 2, Beining Rd., Zhongzheng Dist. Keelung City 202 Taiwan Republic of China hmlin@mail.ntou.edu.tw +886-2-2462-2192 +886-2-2462-2192.ORCID https://orcid.org/0000-0002-1973-2346
National Taiwan Ocean University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we introduced dual-targeting folic acid (FA) and hyaluronic acid (HA) modified on the surface of rice husk mesoporous silica nanoparticles (rMSNs). The rMSNs were employed as a drug delivery system loaded with camptothecin (CPT) as a model drug, Eu

Identifiers

PMID37362343
PMCPMC10288219
OpenAlexW4381848655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.